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Abstract
Protein expression in heterologous hosts for functional studies is a cumbersome effort. Here, we report a superior platform
for parallel protein expression in vivo and in vitro. The platform combines highly efficient ligation-independent cloning (LIC)
with instantaneous detection of expressed proteins through N- or C-terminal fusions to infrared fluorescent protein (IFP).
For each open reading frame, only two PCR fragments are generated (with three PCR primers) and inserted by LIC into ten
expression vectors suitable for protein expression in microbial hosts, including Escherichia coli, Kluyveromyces lactis, Pichia
pastoris, the protozoon Leishmania tarentolae, and an in vitro transcription/translation system. Accumulation of IFP-fusion
proteins is detected by infrared imaging of living cells or crude protein extracts directly after SDS-PAGE without additional
processing. We successfully employed the LIC-IFP platform for in vivo and in vitro expression of ten plant and fungal
proteins, including transcription factors and enzymes. Using the IFP reporter, we additionally established facile methods for
the visualisation of protein-protein interactions and the detection of DNA-transcription factor interactions in microtiter and
gel-free format. We conclude that IFP represents an excellent reporter for high-throughput protein expression and analysis,
which can be easily extended to numerous other expression hosts using the setup reported here.
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Introduction
Genome sequencing has led to the discovery of myriads of new
open reading frames from microbial, plant and animal systems
whose cellular and biochemical functions are often unknown.
Analysis of such proteins generally involves their expression in
heterologous hosts, followed by their purification and biochemical
characterization. However, expression of proteins in alien hosts is
often a difficult and time-consuming task, requiring laborious
screens to identify the optimal expression organism (or strain) and
experimental setup. The situation is further complicated by the
fact that plasmids needed for the transformation of the host strains
are in most cases divergent with respect to their multi-cloning sites,
requesting individual and often complicated (multi-step) cloning
procedures for the insertion of a given open reading frame into
different expression vectors. The establishment of rapid cloning,
expression and protein detection procedures has therefore become
a major field of interest for the design of high-throughput methods
for parallel expression of proteins in multiple expression systems.
To serve rapid cloning, several technologies were established in
recent years including e.g. the commercial Gateway (Invitrogen)
[1,2] and Creator (Clontech) [3] recombination systems and the
proprietary In-Fusion assembly technology (Clontech) likely based
on the 39-.59 exonuclease activity of poxvirus DNA polymerase
generating complementary 15-bp overhangs between target and
destination DNA molecules [4]. Additionally, novel restriction
enzyme/DNA ligase-mediated vector construction methods were
established including BioBrick assembly (http://biobricks.org/)
and Golden Gate cloning [5,6].
Ligation-independent cloning (LIC), sometimes also referred to
as ligase-independent cloning, is a simple, rapid and relatively
cheap method for the generation of expression constructs. It uses
the 39-.59 exonuclease activity of T4 DNA polymerase to create
specific single-stranded, 59-extending tails of ,10–18 nucleotides
in DNA fragments (e.g. PCR amplicons) and complementary
single-stranded overhangs in the target vector. Fragment and
vector are mixed and annealed to each other in the absence of
ligases. Circularization of the vector can only occur after insertion
of the DNA fragments through their cohesive ends. The circular
vector-fragment-annealed DNA is then transformed into Esche-
richia coli, where the newly established plasmids will replicate [7,8].
LIC-compatible vectors contain specifically designed segments
(LIC sites) into which the incoming fragments are cloned.
LIC-compatible vectors have recently been described for various
experimental frameworks, including the high-throughput produc-
tion of recombinant human proteins for crystal structure determi-
nation in bacteria [9], the generation of intron-containing hairpin
RNA constructs for RNAi in plants [10], and the rapid construction
of vectors for targeted mutagenesis in mycobacteria [11].
Next to cloning efficiency, the detection of proteins expressed in
heterologous hosts represents a further experimental challenge.
Although high-throughput protein expression has been described
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[17,18] and for in vitro systems [19], rapid and cheap detection of
recombinantly expressed proteins is still a time-consuming factor
and remains a major bottleneck for multi-parallel expression of
large numbers of different proteins.
Recently, infrared fluorescent protein (IFP) has been engineered
as a new reporter protein, derived from a bacterial (Deinococcus
radiodurans) phytochrome [20]. IFP covalently incorporates biliver-
din, a natural product of heme catabolism involved in aerobic
respiration, and becomes infrared fluorescent with excitation and
emission maxima at 684 nm and 708 nm, respectively. Successful
expression of IFP has been reported for E. coli, human embryonic
kidney cells (HEK293A) and mice [20]. Recently, we demonstrat-
ed that IFP also functions as an excellent reporter for protein
expression in Leishmania tarentolae [21], a unicellular eukaryotic
protozoan for recombinant protein production [22].
Generally, vectors for heterologous protein expression are only
partly standardized, which complicates strategies for expression of
proteins in multiple hosts. Here, we decided to combine the
benefits of LIC (efficient and rapid cloning) and IFP (suitability for
in-cell and in-gel detection) for protein expression in multiple
expression systems in high-throughput. We chose to generate LIC-
compatible vectors for protein expression in Escherichia coli and
Pichia pastoris [23]. According to recent data 80% of all
recombinant proteins are currently expressed in these two
organisms. However, as these expression systems are often
inadequate for expression of eukaryotic proteins, the use of
alternative and less frequently used systems has been recom-
mended [24]. We therefore included the yeast Kluyveromyces lactis
[25] and the protozoan Leishmania tarentolae [22] as two additional,
eukaryotic expression hosts in our setup. Finally, the LIC-
compatible cloning system was also established for in vitro protein
expression (Fig. 1).
To demonstrate the capacity of our platform we generated ten
LIC-compatible vectors for oriented insertion of open reading
frames and then built 54 constructs for the expression of eight
different plant and two fungal proteins, including transcription
factors and enzymes, in the five production systems. All vectors
support the expression of proteins with either N- or C-terminal
fusions to the IFP reporter and a 6xHis-tag enabling rapid
identification of well-expressing host strains or in vitro expression
conditions by in-cell, in-gel and immunological detection as well as
protein purification by affinity chromatography. Additionally, the
marker proteins can be cleaved off by treatment with Tobacco
Etch Virus (TEV) protease recognizing a cognate TEV cleavage
site [26] included in all proteins.
With the vectors generated here we observed 100% cloning
efficiency in almost all experiments, i.e. virtually all LIC-inserted
PCR fragments were present in correct orientation after restriction
analysis and were free of sequencing errors and out-of-frame
fusions after sequencing. Additionally, IFP-labelled fusion proteins
were detected in all cases, eight in vitro, eleven in E. coli, five in K.
lactis, four in P. pastoris and seven in L. tarentolae. Four IFP fusion
proteins expressed in E. coli were used for functionality analysis,
resulting in successful purification by 6xHis affinity chromatogra-
phy and time-dependent TEV protease cleavage of the 6xHis and
IFP reporter proteins. Our platform, which requires minimal effort
for designing appropriate cloning strategies, allows for simple
screening of optimal expression systems and provides a fertile tool
for proteomics research. As examples we demonstrate that IFP
fusion proteins can be employed for in vitro protein-protein
interaction studies as well as for the analysis of DNA-transcription
factor interactions, making IFP fusions amenable to high-
throughput screening processes. IFP fusion proteins are conve-
niently detected by infrared imaging in microtiter plates, or after
SDS-polyacrylamide gel electrophoresis in cast protein gels. After
pull-down, IFP fusion proteins can thus be directly visualized by
infrared imaging making additional experimental steps such as
western blotting or autoradiography of radioactively labelled
proteins frequently used in such studies [27,28] obsolete. Finally,
we demonstrated enzymatic activity of two selected IFP fusion
proteins. Our IFP fusion protein tool box offers an easy-to-handle
platform for protein expression and facilitates the analysis of
protein-protein and protein-DNA interactions.
Materials and Methods
Chemicals
Biliverdin hydrochloride was purchased from Frontier Scientific
(Carnforth, Lancashire, UK). Hemin was ordered from Sigma-
Aldrich (Deisenhofen, Germany).
Constructs
General. IFP-LIC compatible in vitro, E. coli, K. lactis, P.
pastoris and L. tarentolae protein expression vectors were generated
by using the commercial vectors pIVEX2.4d/2.3d (Roche,
Mannheim, Germany), pDEST15 (Invitrogen, Karlsruhe,
Germany), pKLAC1 (New England Biolabs, Frankfurt am Main,
Germany), pPICZ-aA (Invitrogen), and pLEXSY-sat2 (Jena
Bioscience, Jena, Germany). The IFP-LIC vectors were generally
denoted as LIC-X-LC1 or LIC-X-LC2, where ‘X’ refers to the
original vectors (pIVEX, pDEST, pKLAC, pPICZ and pLEXSY),
that were used to construct the LIC-compatible vectors (Fig. 2).
‘LC1’ indicates positioning of the LIC site downstream of the
6xHis-IFP-TEV fusion segment (downstream of the C-terminus of
the TEV protease cleavage site). ‘LC2’ indicates the LIC site to be
located upstream of the TEV-IFP-6xHis fusion segment (upstream
of the N-terminus of the TEV cleavage site). The LIC fragment is
identical in all vectors and was designed on the basis of a stuffer
fragment derived from the L. tarentolae expression vector pLEXSY-
sat2 (Jena Bioscience) to which we added by PCR the LIC
annealing sites LCA and LCB at both ends. Both LIC sites include
a PmeI restriction site (Fig. 2). For PCR amplification of the IFP
open reading frame the pENTR1A-IFP1.4&GFP vector [20] was
used as template. IFP-LIC compatible vectors were generated as
described below (for primer sequences see Table S1). Vector
sequences were deposited in GenBank under the following
accession numbers: LIC-pIVEX-LC1, JF327844; LIC-pIVEX-
LC2, JF327845; LIC-pDEST-LC1, JF327846; LIC-pDEST-LC2,
JF327847; LIC-pKLAC-LC1, JF327848; LIC-pKLAC-LC2,
JF327849; LIC-pPICZ-LC1, JF327850; LIC-pPICZ-LC2,
JF327851; LIC-pLEXSY-LC1, JF327852; LIC-pLEXSY-LC2,
JF327853.
LIC-pIVEX-LC1 – in vitro expression vector. The IFP
open reading frame was amplified by PCR using primers P294
and P295. The LIC sequence was amplified using primers P296
and P297. Subsequently, the PCR products were used for fusion-
PCR with primers P294 and P297. The final PCR product, called
IFP-TEV-LIC, was cloned by restriction and ligation into the NotI
and BamHI sites of the pIVEX2.4d vector, resulting in the in vitro
expression vector LIC-pIVEX-LC1 encoding for N-terminal
6xHis-FactorXa-IFP-TEV fusion proteins if LIC is performed.
LIC-pIVEX-LC2 - in vitro expression vector. The LIC
fragment was amplified by PCR using primers P298 and P299.
The IFP open reading frame was amplified using primers P300
and P283. Both PCR products were used in a fusion-PCR with
primers P298 and P283. The fusion-PCR product, called LIC-
TEV-IFP, was cloned by restriction and ligation into the NcoI and
LIC-IFP Based Protein Expression Platform
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expression vector LIC-pIVEX-LC2 encoding for C-terminal
TEV-IFP-6xHis fusion proteins if LIC is performed.
LIC-pDEST-LC1 – E. coli expression vector. This vector
was generated by amplification of 6xHis-IFP coding region in a
two-step PCR. For the first reaction, PCR primers P301a and
P295 were used. The resulting PCR product was used as template
for the second PCR with primers P301b and P295, yielding
fragment 6xHis-IFP. The LIC sequence, which was later used for
the fusion-PCR with the 6xHis-IFP PCR product, was amplified
with primers P296 and P297. Fusion-PCR with the PCR products
6xHis-IFP and LIC was done using primers P301b and P297,
resulting in the PCR product 6xHis-IFP-TEV-LIC. This product
was cloned by restriction and ligation into the NdeI and BamHI
sites of the vector pDEST15 (Invitrogen). The resulting E. coli
expression vector was named LIC-pDEST-LC1; it encodes for N-
terminal 6xHis-IFP-TEV fusion proteins if LIC is performed.
LIC-pDEST-LC2 – E. coli expression vector. This vector
was generated by using the pHEST-IFP vector encoding for the
IFP-6xHis fusion protein. The pHEST-IFP vector was generated
by cloning of IFP-6xHis encoding sequence, with a KpnI
restriction site between the IFP and the 6xHis moieties, into the
NdeI and BamHI sites of the pDEST15 vector. For the
amplification of the LIC fragment, PCR primers P302 and P299
were used. IFP was amplified using primers P300 and P303. The
resulting PCR products were used for fusion-PCR with primers
P302 and P303 to generate the LIC-TEV-IFP-6xHis cassette for
cloning by restriction and ligation into the NdeI and KpnI sites of
the vector pHEST-IFP. The resulting E. coli expression vector was
called LIC-pDEST-LC2 encoding for C-terminal TEV-IFP-6xHis
fusion proteins if LIC is performed.
LIC-pKLAC-LC1 - K. lactis expression vector. This vector
was generated by amplification of 6xHis-IFP in a two-step PCR
reaction. Primers P301a and P295 were used for the first reaction.
Figure 1. Rapid and parallel cloning using LIC-compatible expression vectors. Only two PCR fragments, one with and one without stop
codon, are needed per target open reading frame for rapid and parallel insertion into ten LIC-compatible vectors. The vectors allow facile protein
expression in four different hosts, i.e. E. coli, K. lactis, P. pastoris and L. tarentolae, and by in vitro transcription/translation. Vectors were constructed to
support production of N- and C-terminal fusions to the IFP- and 6xHis-tags. The IFP moiety enables detection of IFP fusion proteins by easy-to-handle
in-cell and in-gel infrared imaging, and the 6xHis-tag allows immunological detection of fusion proteins and affinity purification. A TEV protease
cleavage site (not indicated) allows removal of the IFP- and 6xHis-tags. Photographs provided by: Wikipedia (E. coli); Linda Silveira, University of
Redlands, California, USA (K. lactis); Dennis Kunkel, Dennis Kunkel Microscopy, Inc., Hawaii, USA (P. pastoris); Jena Bioscience, Jena, Germany (L.
tarentolae).
doi:10.1371/journal.pone.0018900.g001
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second PCR with primers P312 and P295, resulting in fragment
6xHis-IFP. The LIC fragment, later used for the fusion-PCR with
the 6xHis-IFP PCR product, was amplified with primers P296 and
P305. Fusion-PCR with the PCR products 6xHis-IFP and LIC
was done using primers P312 and P305. The resulting PCR-
product was named 6xHis-IFP-TEV-LIC. This product was
cloned by restriction and ligation into the HindIII and NotI sites
of the vector pKLAC1 (NEB). The resulting K. lactis expression
vector was named LIC-pKLAC-LC1 encoding for N-terminal
6xHis-IFP-TEV fusion proteins if LIC is performed.
LIC-pKLAC-LC2 - K. lactis expression vector. The LIC
fragment was PCR amplified with primers P313 and P299. The
IFP-6xHis sequence was amplified in a two-step PCR reaction.
For the first reaction, PCR primers P300 and P314a were used.
The resulting PCR product was used as template for the second
PCR with primers P300 and P314b, resulting in fragment IFP-
6xHis. Fusion-PCR with the PCR products LIC and IFP-6xHis
was done using primers P313 and P314b, resulting in the PCR-
product LIC-TEV-IFP-6xHis. This product was cloned by
restriction and ligation into the HindIII and NotI sites of the
vector pKLAC1. The resulting K. lactis expression vector was
named LIC-pKLAC-LC2 encoding for C-terminal TEV-IFP-
6xHis fusion proteins if LIC is performed.
LIC-pPICZ-LC1 - P. pastoris expression vector. Before
generating the LIC-IFP compatible P. pastoris expression vectors
(LIC-pPICZ-LC1 and LIC-pPICZ-LC2) a PmeI restriction site
located within the 59 AOX1 promoter (at position 410–418 bp) of
the pPICZ-aA vector was eliminated by changing the PmeI
restriction site GTTTAAAC to GTTTAAAG. To this end, the
vector was digested with PmeI and BstXI resulting in two
fragments (3300 bp and 293 bp). The short fragment was used as
template for PCR amplification with primers F-NoPmeI, (59-
AAAGGCTGTCTTGGAACC-39) and R-NoPmeI (59-ATA-
AGAATCCAGAATCTTGGAA-GCATAC-39) to produce a
DNA fragment lacking the PmeI restriction site. This PCR
product was digested with BstXI and ligated back into the large
3300-bp fragment.
The resulting pPICZ-aA vector lacking the PmeI restriction site
(named pPICZ-aA-DPme) was used to generate the LIC-pPICZ-
LC1 vector by PCR amplification of the 6xHis-IFP fragment in a
two-step PCR. For the first reaction, PCR primers P301a and
P295 were used. The resulting PCR product was used as template
for the second PCR with primers P308 and P295, resulting in the
fragment 6xHis-IFP. The LIC fragment was amplified with
primers P269 and P309. Fusion-PCR with the PCR products
6xHis-IFP and LIC was done using primers P308 and P309,
resulting in the PCR product 6xHis-IFP-TEV-LIC. This product,
digested with AclI and SalI, was cloned by restriction and ligation
into the BstBI and SalI sites of the vector pPICZ-aA-DPme. The
resulting P. pastoris expression vector was named LIC-pPICZ-LC1
encoding for N-terminal 6xHis-IFP-TEV fusion proteins if LIC is
performed.
LIC-pPICZ-LC2 - P. pastoris expression vector. The LIC
fragment was amplified by PCR with the primers P310 and P299,
and the IFP open reading frame with primers P300 and P311.
Fusion-PCR with the PCR products LIC and IFP was done using
primers P310 and P311. The resulting PCR product was named
LIC-TEV-IFP and cloned after AclI and SalI digestion by
restriction and ligation into the BstBI and SalI sites of the
pPICZ-aA-DPme vector. The resulting P. pastoris expression vector
was named LIC-pPICZ-LC2 encoding for C-terminal TEV-IFP-
6xHis fusion proteins if LIC is performed.
LIC-pLEXSY-LC1 - L. tarentolae expression vector. The
6xHis-IFP fragment was amplified by PCR in a two-step PCR
using primers P301a and P295 in the first reaction. The resulting
PCR product was used as template for the second PCR with
primers P304 and P295. The LIC fragment was amplified with
primers P296 and P305. Both PCR products were used in a fusion-
PCR with primers P304 and P305. The fusion-PCR product,
called 6xHis-IFP-TEV-LIC, was cloned by restriction and ligation
into the NcoI and NotI sites of the pLEXSY-sat2 vector, resulting
in the L. tarentolae expression vector LIC-pLEXSY-LC1 encoding
for N-terminal 6xHis-IFP-TEV fusion proteins if LIC is
performed.
LIC-pLEXSY-LC2 - L. tarentolae expression vector. The
LIC fragment was amplified by PCR with primers P298 and P299.
The IFP fragment was amplified by PCR with primers P300 and
P303. The resulting PCR products were used in a fusion-PCR
with primers P298 and P303. The fusion-PCR product, called
LIC-TEV-IFP, was cloned by restriction and ligation into the
NcoI and KpnI sites of the pLEXSY-sat2 vector. The resulting L.
tarentolae expression vector was called LIC-pLEXSY-LC2 encoding
for C-terminal TEV-IFP-6xHis fusion proteins if LIC is
performed.
Ligation-independent cloning
Linearization of LIC expression vectors for LIC
cloning. LIC expression vectors (10 mg) were cut with 10 U
PmeI in a 20-mL reaction volume and purified from contaminating
stuffer fragment and undigested vector by gel-extraction using the
NucleoSpin Extract II kit (Macherey & Nagel, Du ¨ren, Germany).
To generate 59 LIC overhangs (15 and 16 nt, respectively) at both
ends the purified vector backbone was treated for 30 min (22uC)
Figure 2. LIC-compatible expression vectors. The pool of LIC-
compatible vectors comprises vectors for expression of IFP fusion
proteins in multiple expression systems, i.e. in vitro (LIC-pIVEX-LC1/-LC2)
and in vivo in E. coli (LIC-pDEST-LC1/-LC2), K. lactis (LIC-pKLAC-LC1/-
LC2), P. pastoris (LIC-pPICZ-LC1/-LC2) and L. tarentolae (LIC-pLEXSY-
LC1/-LC2). The pool includes LC1 and LC2 vectors encoding 6xHis-IFP-
TEV-ProteinX and ProteinX-TEV-IFP-6xHis fusions, respectively, after
ligation-independent cloning of ProteinX-encoding open reading
frames into the LCA and LCB sites. The maker proteins IFP and 6xHis
can be cleaved off at the TEV protease cleavage site next to a PmeI site
used for LIC. LCA and LCB sites are introduced into target open reading
frames by PCR. The LIC fragment was designed on the basis of a 670-bp
stuffer fragment, flanked by the LIC annealing sites LCA and LCB,
respectively, both of which encompass a PmeI restriction site. The stop
codon of LC2 vectors is provided by the vector whilst for LC1 vectors it
has to be added by the reverse primer during PCR amplification of the
target open reading frame.
doi:10.1371/journal.pone.0018900.g002
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following reaction setup: 0.2 pmol purified vector backbone, 2 mL
106 buffer 2 (NEB), 2 mL dATP (25 mM), 1 mL dithiothreitol
(DTT, 100 mM), 2 mL1 0 6 (10 mg/mL) bovine serum albumin
(BSA; NEB), 10 U T4 DNA polymerase (NEB) in a volume of
20 mL (filled up with ddH2O). The reaction mix was heat
inactivated for 20 min at 75uC, followed by purification using
the NucleoSpin Extract II kit (Macherey & Nagel) and elution with
20 mL elution buffer included in the kit. Two-mL aliquots were
stored at 20uC before LIC cloning was performed.
Primer design and preparation of PCR products for LIC
cloning. For directional and in-frame cloning of PCR-amplified
open reading frames into LIC-X-LC1 or LIC-X-LC2 vectors,
sense primers starting with the following sequence were used: 59-
TGGGTTCTTCTGTTTCC(ATG)-39 (the ATG nucleotides in
brackets indicate the gene’s start codon). Antisense primers
for cloning into LIC-X-LC1 expression vectors must start with
the sequence 59-GGTTCTCGCCCTGTTTACC(CTATTA)-39
(brackets indicate a TAATAG double stop codon). Antisense
primers for cloning into LIC-X-LC2 expression vectors must start
with the sequence 59-GGTTCTCGCCCTGTTTACC-39 lacking
a stop codon. Complementary LIC overhangs within the sense
and antisense primers are underlined (for full primer sequences see
Table S2). The cDNAs encoding for the Arabidopsis thaliana
proteins TPK1, SAM1, ACO1, ACS2, ANAC042, ANAC059,
BGAL4 and BGAL10 were amplified by PCR, respectively, using
cDNAs of TPK1 (AGI: At5g55630), SAM1 (At1g02500), ACO1
(At2g19590), ACS2 (At1g01480), ANAC042 (At2G43000), and
ANAC059 (At3g29035) as templates. BGAL4 (At5g56870) and
BGAL10 (At5g63810) encoding vectors (pda07078 and pda08126)
were purchased from the RIKEN Bio Resource Centre (Japan).
For TPK1, a partial cDNA encoding the N-terminal part of the
channel protein (amino acids 1-79) was used [29]. Open reading
frames of two cell wall degrading enzymes endo-b-1,4-glucanase
(GenBank ID DQ490472) and endo-b-1,4-xylanase (DQ490490)
were PCR amplified using genomic DNA from Pichia pastoris
strains obtained from the Fungal Genetic Stock Centre (FGSC)
[30]. PCR products were treated at 22uC for 30 min with T4
DNA polymerase in the presence of dTTP, using the following
reaction setup: 0.2 pmol purified PCR product, 2 mL1 0 6buffer 2
(NEB), 2 mL dATP (25 mM), 1 mL DTT (100 mM), 2 mL1 0 6
BSA (10 mg/mL; NEB), 1 U T4 DNA polymerase (NEB) in a
volume of 20 mL (filled up with ddH2O). The reaction mix was
heat inactivated for 20 min at 75uC, followed by purification using
the NucleoSpin Extract II kit (Macherey &Nagel) and eluting with
20 mL elution buffer included in the kit. Two-mL aliquots were
stored at 220uC before LIC cloning was performed.
LIC cloning of target genes. 0.02 pmol (1 mL) and
0.04 pmol (2 mL) of pre-treated LIC vectors and PCR products
(see above) were mixed and incubated for 1 h at 22uC. The
reaction mix was supplemented with 1 ml EDTA (25 mM),
followed by incubation for 10 min at 22uC and transformation
of the whole reaction mix into E. coli for plasmid amplification.
Gateway cloning of cDNAs encoding GRFs
The open reading frames of GRF1 (AGI code: At4g09000),
GRF2 (At1g78300), GRF3 (At5g38480), GRF4 (At1g35160), GRF5
(At5g16050) and GRF6 (At5g10450) were amplified by PCR using
respective cDNA clones as templates and recombined into entry
vector pDONR201 using Gateway technology (Invitrogen).
Primers containing the Gateway attB1 and attB2 sites are listed
in Table S3. The identities of all cloned cDNAs were verified by
sequencing. For protein expression and purification, GRF1 – GRF6
open reading frames were recombined in vitro from the entry
vectors into the Gateway destination vector pDEST15 (Invitrogen)
encoding an N-terminal GST-tag. The resulting expression vectors
were named pDEST15-GRF1/2/3/4/5/6.
Protein expression
Protein expression in vitro. For in vitro transcription/
translation LIC-pIVEX-LC1/LC2 plasmid templates were
purified using the NucleoSpin Plasmid miniprep kit (Macherey
& Nagel). The RTS 100 E. coli HY kit (Roche) was used to set up
50-mL reactions in 1.5-mL plastic tubes. Reactions were incubated
for 5 h at 30uC, followed by incubation for 30 min at 26uC in the
presence of 25 mM biliverdin hydrochloride. Samples (10–20 mL)
were separated by SDS-PAGE and analysed by in-gel detection or
western blot and infrared analysis as described [21].
Protein expression in E. coli and TEV protease
cleavage. For protein expression in E. coli LIC-pDEST-LC1/
LC2 plasmid templates were transformed into different expression
strains, i.e. BL21 (DE3) pLysS (Agilent Technologies, Waldbronn,
Germany), BL21 (DE3) CodonPlus-RIL (Agilent Technologies),
and Rosetta (DE3) pRARE (Merck, Darmstadt, Germany).
Furthermore, plasmid pRARE was isolated from Rosetta (DE3)
pRARE cells and used to transform E. coli BL21 Star (DE3)
(Invitrogen) to generate the expression strain BL21 Star (DE3)
pRARE. Expression of IFP fusion proteins was induced at 30uCi n
LB medium (2 mL in 24-deep-well plates) supplemented with
25 mM biliverdin hydrochloride by 1 mM isopropyl thio-b-D-
galactoside (IPTG) for 4 h. Hundred mL of the induced cell
cultures were then used for in-cell detection by infrared imaging.
Cells from 1 mL of culture were harvested after 4 h of induction
and lysed by sonication in 100 mL lysis buffer (20 mM sodium
phosphate buffer, pH 7.3, 150 mM NaCl, 1 mM EDTA, 1 mM
DTT, 1 mM phenylmethanesulfonyl fluoride (PMSF), 2 mM
benzamidin, 10 mgm L
21 aprotonin, 10 mgm L
21 leupeptin).
Cell extracts were ultracentrifuged and 20 mL of the pellet and
supernatant were used for SDS-PAGE separation followed by in-
gel detection or western blot and infrared analysis [21]. Protein
expression for the purification of GST (empty pDEST15 vector) or
GST-GRF fusion proteins (pDEST15-GRF1/2/3/4/5/6 vectors)
was carried out in 100 mL culture volume in BL21 (DE3) pLysS
(Agilent Technologies) cells (30uC, 1 mM IPTG, 4 h), followed by
sonication of cells in 10 mL lysis buffer as described above.
Supernatants of ultracentrifuged cell extracts were used for
purification by GST affinity chromatography (see below).
Expression for purification of 6xHis-IFP-TEV-SAM1 and -
ACO1 as well as ANAC042- and ANAC059-TEV-IFP-6xHis
fusion proteins was carried out in 100-mL culture volumes in
BL21 (DE3) pLysS (6xHis-IFP-TEV-SAM1/–ACO1) or BL21
Star (DE3) pRARE (ANAC042- and ANAC059-TEV-IFP-6xHis)
cells (30uC, 1 mM IPTG, 4 h) in the absence of biliverdin
hydrochloride, followed by sonication of cells in 5 mL lysis buffer
(see above) supplemented with 25 mM biliverdin hydrochloride
and 0.1 mM EDTA. The low EDTA concentration (0.1 mM) was
used instead of 1 mM to minimize damaging of the columns used
for purification of 6xHis fusion proteins. Supernatant fractions of
ultracentrifuged cell extracts were used for TEV cleavage
experiments and protein purification. For TEV cleavage
experiments 160 mL of the protein samples were supplemented
with 0.4 mM EDTA and incubated with 10 U AcTEV-Protease
(Invitrogen) at 26uC. After 1 h, 2 h and 4 h of incubation 40-mL
aliquots were separated by SDS-PAGE and analyzed by in-gel
detection followed by Coomassie staining.
Protein expression in K. lactis. LIC-pKLAC-LC1/LC2
plasmid templates were used for protein expression in K. lactis
using the K. lactis Protein Expression Kit (NEB) as described in the
LIC-IFP Based Protein Expression Platform
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respectively, of incubation 100 mL of galactose-induced IFP
fusion protein-expressing cells were used for in-cell detection. To
this end, cell cultures were supplemented with hemin (10 mg/mL)
and incubated for further 2 h to trigger the formation of
chromophore-attached IFP. The cell line producing the strongest
infrared signal was scaled up in 100 mL culture volume for in-gel
detection or western blot and infrared analysis. To this end, cells
were harvested and lysed with 20 mL lysis buffer (see above,
protein expression in E. coli) at 2,000 bar using an EmulsiFlex-C5
high-pressure homogenizer (Avestin Europe, Mannheim,
Germany). Crude extracts were ultracentrifuged and 20 mLo f
the pellet and supernatant were used for SDS-PAGE separation
followed by in-gel detection or western blot and infrared analysis
[21].
Protein expression in P. pastoris. LIC-pPICZ-LC1/LC2
plasmid templates were used for protein expression in P. pastoris
using the EasySelect Pichia Expression kit (Invitrogen), as described
in the manufacturer’s instructions. After three, four and five days,
respectively, of incubation 100 mL of methanol-induced IFP fusion
protein-expressing cells were used for in-cell detection. To this
end, cell cultures were supplemented with hemin (10 mg/mL) and
incubated for further 2 h to trigger the generation of infrared
signal. The cell line producing the strongest infrared signal was
scaled up in 100 mL culture volume for in-gel detection or western
blot and infrared analysis after 24 h of induction with methanol.
Cells were harvested and processed further as described above
(protein expression in K. lactis).
Protein expression in L. tarentolae. LIC-pLEXSY-LC1/
LC2 plasmid templates were used for protein expression in L.
tarentolae using the LEXSYcon2 Expression Kit (Jena Bioscience) as
described before [21]. One hundred mL of IFP fusion protein
expressing cells were used for in-cell detection and 8 mL of
harvested cells were lysed with 100 mL of lysis buffer (see above,
protein expression in E. coli) and sonication after five days of
incubation. Crude extracts were ultracentrifuged and 20 mL of the
pellet and supernatant were used for SDS-PAGE separation
followed by in-gel detection or western blot and infrared analysis.
Protein purification
Purification of GST fusion proteins. Supernatant of
centrifuged samples was used for purification using a 1-mL
GSTrap HP column (GE Healthcare, Munich, Germany) coupled
to the A ¨kta-Purifier FPLC system (GE Healthcare). Aliquots of the
flow through fractions were analysed by SDS-PAGE and
Coomassie staining. One-mL elution fractions containing the
purified GST-GRF fusion proteins were pooled and dialyzed
against PBS buffer (20 mM Na-phosphate, pH 7.4, 150 mM
NaCl) in order to remove reduced glutathione from the elution
buffer which is essential for subsequent pull-down analysis.
Purification of 6xHis fusion proteins. For the purification
of the fusion proteins IFP-6xHis and TPK1-TEV-IFP-6xHis, L.
tarentolae cells from nine 150 cm
2-tissue culture flasks each
containing 60 mL of non-selective expression medium were
pooled and centrifuged. Cell pellets were resuspended in 10 mL
standard Tris buffer supplemented with protease inhibitors (1 mM
PMSF and EDTA-free protease inhibitor cocktail). Resuspended
cells were sonicated and the supernatants of ultracentrifuged
samples were used for purification. Proteins were purified using a
1-mL HisTrap HP column (GE Healthcare) coupled to the A ¨kta-
Purifier FPLC system. For purification of the 6xHis-IFP-TEV-
SAM1/-ACO1 and ANAC042-/ANAC059-TEV-IFP-6xHis
fusion proteins, resuspended E. coli cell pellets were sonicated
and the supernatants of ultracentrifuged samples were used.
Proteins were purified using Protino Ni-IDA 150 packed columns
(Macherey & Nagel) according to the instructions of the
manufacturer.
Infrared analysis of IFP fusion proteins
For in-cell detection of protein expression, IFP fusion protein-
expressing in vitro samples (50 mL) and cells (100 mL) were
transferred into the wells of clear 96-well microtiter plates with
round bottom (Corning, New York, USA) followed by infrared
scan at 700 nm using the Odyssey Infrared Imaging System (LI-
COR Biosciences, Bad Homburg, Germany) as described before
[21].
Protein samples were separated in 12% SDS-polyacrylamide
gels using the Mighty Small II system (Hoefer, Massachusetts,
USA) and analysed by (i) in-gel detection or (ii) immunologically.
(i) For in-gel detection of the IFP moiety IFP fusion proteins were
visualized after SDS-PAGE (without demounting cast protein gels)
at 700 nm using the Odyssey Infrared Imaging System (LI-COR)
as described before [21] and presented in grey- or red-scale. All in-
gel detections were done in the presence of the PageRuler Plus
Prestained Protein ladder (Fermentas, St. Leon-Rot, Germany)
containing two red pre-stained marker proteins (28 and 72 kDa)
visible at day light, but invisible upon excitation at 700 nm. All
other marker proteins are pre-stained in blue resulting in a green
fluorescent signal at 700 nm. ii) For immunological analysis SDS-
PAGE-separated proteins were transferred onto Protran nitrocel-
lulose membrane (Whatman, Kent, UK). The membrane was
blocked for 1 h in blocking buffer (5% non-fat dry milk in PBS
containing 0.1% Tween-20), followed by incubation for 1 h with
first monoclonal mouse antibody directed against the 6xHis
epitope (Santa Cruz Biotechnology, Heidelberg, Germany).
Membranes were washed three times for 10 min in washing
buffer (PBS containing 0.1% Tween-20) and incubated for 1 h
with IRDye800CW-conjugated goat anti-mouse secondary anti-
body (LI-COR). All incubations were performed at room
temperature and antibodies were diluted 1:10,000 in blocking
buffer. Signal intensities were analysed at 800 nm by using the
Odyssey Infrared Imaging System (LI-COR).
In vitro protein-protein and protein-DNA interaction
assays
Protein-protein interaction analysis. For protein pull-
down assays concentrations of purified GST and GST-GRF
fusion proteins were estimated by SDS-PAGE and Coomassie
staining using bovine serum albumin (BSA) as standard. In vitro
protein-protein interaction assays were performed by using
magnetic glutathione agarose beads of the MagneGST pull-
down system (Promega, Mannheim, Germany). To this end,
20 mL of the magnetic particles were pretreated according to the
manufacturer’s instructions by incubation at room temperature for
30 min with 30% BSA. Equal amounts of purified GST and GST-
GRF fusion proteins (5 mg) were immobilized on pretreated
magnetic glutathione agarose beads in the presence of 0.5%
Nonidet-P40 and 10% BSA by incubation at room temperature
for 30 min. Immobilized GST and GST-GRF fusion proteins
were incubated with equal amounts of purified IFP-6xHis and
TPK1(1-79)-TEV-IFP-6xHis fusion proteins (1 mg) at room
temperature for 60 min and washed five times with 400 mLo f
washing buffer supplemented with 0.5% Nonidet-P40. Eluted
proteins were analyzed by infrared imaging (as described above) in
microtiter plates followed by SDS-PAGE separation and in-gel
detection.
Protein-DNA interaction analysis. DNA pull-down assays
were carried out in three steps, i) immobilization of biotinylated
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Matrix (Roche), ii) incubation of immobilized DNA with protein,
and iii) elution of DNA-protein complex followed by infrared
detection of interacting IFP fusion protein in microtiter plates, by
in-gel detection and western blot analysis.
i) Biotinylated double-stranded DNA molecules (50 bp), B-100%-
DNAand B-7%-DNA,weregeneratedbyannealing equimolarnon-
biotinylated forward oligonucleotides (2000 pmol) and their com-
plementary 59-biotinylated reverse oligonucleotides (2000 pmol) in a
hybridization reaction for 30 min at room temperature. Forward




GC-CTT-39. The two characteristic nucleotides discriminating the
100%-DNA sequence from the 7%-DNA sequence are labeled by
squared parentheses. Nucleotide sequences of the ANAC042
binding sites are typed in bold and flanked by additional constant
nucleotides (five nucleotides at the 59-end and 27 nucleotides at the
39-end). For the immobilization reaction 100 mLo fc e n t r i f u g e d
streptavidin mutein particles were pretreated according to the
instructions of the manufacturer. Equal amounts of biotinylated
double-stranded DNA oligonucleotides (4000 pmol each) were
immobilized on equilibrated streptavidin mutein beads by incuba-
tion at room temperature for 10 min followed by washing three
times with 400 mL washing buffer (see manual Streptavidin Mutein
Matrix).
ii) Concentrations of purified IFP-6xHis and ANAC042-TEV-
IFP-6xHis fusion proteins were estimated by SDS-PAGE and
Coomassie staining using BSA as standard. Immobilized double-
stranded DNA molecules were incubated with equal amounts of
purified ANAC042-TEV-IFP-6xHis (experiment) and IFP-6xHis
(negative control) fusion proteins (,5 mg) at room temperature for
60 min in a total volume of 700 mL containing as competitors
either 4000 pmol of non-biotinylated 7%-DNA (used for immo-
bilized B-100%-DNA) or non-biotinylated 100%-DNA (used for
immobilized B-7%-DNA). Samples were washed three times with
400 mL washing buffer (see manual Streptavidin Mutein Matrix).
iii) Interacting DNA-protein complexes were eluted from the
streptavidin mutein matrix with 70 mL elution buffer (see manual
Streptavidin Mutein Matrix). Proteins (50 mL) were analyzed by
infrared imaging in microtiter plates, followed by SDS-PAGE
separation and in-gel detection or western blot analysis. Signal
intensities in microtiter plates were used for quantification of
protein-DNA interactions using the Odyssey Infrared Imaging
System (LI-COR).
Enzymatic activity assays of IFP fusion proteins
Enzymatic activity assays were carried out with two cell wall
degrading enzymes, endo-b-1,4-glucanase and endo-b-1,4-xyla-
nase, after LIC of their open reading frames into the vectors LIC-
pDEST-LC1 and -LC2. The resulting expression constructs,
encoding for the fusion proteins 6xHis-IFP-TEV-endo-b-1,4-
glucanase/-endo-b-1,4-xylanase and endo-b-1,4-glucanase-/
endo-b-1,4-xylanase-TEV-IFP-6xHis, respectively, were trans-
formed into different E. coli expression strains. Protein-expressing
transformants were grown over-night in 3 mL medium in the
presence of antibiotics. Subsequently, 2 mL of the E. coli cultures
were transferred to petri dishes containing selection medium
supplemented with 2 mM IPTG and 0.2% carboxymethylcellu-
lose (CMC; Sigma-Aldrich) or birch wood xylan (Roth, Karlsruhe,
Germany) for glucanase or xylanase activity assays, respectively.
After over-night growth at 37uC, plates were stained with Congo
Red to detect enzyme activities, as described by Pointing [31].
Results
Construction of LIC-compatible expression vectors
A set of ten LIC-compatible vectors for in vitro and in vivo protein
expression were constructed by inserting PCR-generated oligonu-
cleotide fragments into the multiple cloning sites of commercially
available expression vectors. All proteins expressed from these
vectors contain a TEV protease cleavable site and both, an IFP-
and 6xHis-tag for protein detection. Vectors were constructed in
two ways, to allow expression of fusion proteins with either the
6xHis-tag/IFP-tag/TEV cleavage site at the N-terminus (LC1
vectors; 6xHis-IFP-TEV-ProteinX), or the TEV cleavage site/
IFP-tag/His-tag at the C-terminus (LC2 vectors; ProteinX-TEV-
IFP-6xHis) (Fig. 2). All vectors described here were shown to be
functional (see below).
For in vitro expression, LIC-compatible vectors were derived from
the pIVEX2.4d and pIVEX2.3d vectors (Roche). Vectors
pDEST15 (Invitrogen), pKLAC1 (NEB), pPICZ-aA (Invitrogen)
and pLEXSY-sat2 (Jena Bioscience) were made LIC-compatible for
in vivo expression in E. coli, K. lactis, P. pastoris and L. tarentolae,
respectively. Before conversion into a LIC-compatible Pichia
expression vector an internal PmeI restriction site had to be
eliminated from the pPICZ-aA vector resulting in vector pPICZ-
aA-DPmeI. The successfully constructed LIC vectors, all verified by
sequencing, were named LIC-pIVEX-LC1/-LC2, LIC-pDEST-
LC1/-LC2, LIC-pKLAC-LC1/-LC2, LIC-pPICZ-LC1/-LC2 and
LIC-pLEXSY-LC1/-LC2, respectively. LC1 vectors encode for
amino acid sequences consisting of an N-terminal 6xHis-tag, IFP-
tag and the ENLYFQG TEV cleavage site followed by the LIC site
for insertion of target open reading frames. LC2 vectors encode for
amino acid sequences consisting of an N-terminal LIC site for
insertion of target open reading frames, followed by the ENLYFQG
TEV cleavage site and the IFP- and 6xHis-tags (Fig. 3). To allow
rapid insertion of PCR-generated open reading frames into the
various vectors, the LIC sites were all made identical in the N- and
C-terminal fusion vectors, respectively. Thus, PCR amplification of
open reading frames for expression from ten different plasmids in
four hosts and one in vitro transcription/translation system requires
only three primers for the generation of two PCR amplicons.
To increase cloning efficiency we inserted a 670-bp long stuffer
fragment, flanked by two LIC annealing sites, called LCA (15 nt)
and LCB (16 nt), into each LIC-compatible vector. Each LIC site
includes a PmeI restriction site (Fig. 3). Cutting the LIC vector
with PmeI releases the stuffer fragment, leaving behind blunt-
ended, linearized vector amenable for generation of 59 single-
strand overhangs by T4 DNA polymerase (see below). The TEV
cleavage site is in close proximity to the native protein and allows
removing the IFP- and 6xHis-tags, leaving nine amino acid
residues at the N-terminus of the target proteins expressed from
LC1 vectors, and ten amino acid residues at the C-terminus of the
target proteins expressed from LC2 vectors (Fig. 3).
Characterization of LIC-compatible expression vectors
The newly generated and sequence-confirmed LIC vectors were
analysed for rapid, parallel and efficient LIC by generating expression
constructs encoding for different proteins derived from the plant
Arabidopsis thaliana: the transcription factors ANAC042 (AGI code
At2g43000) and ANAC059 (At3g29035), the ethylene-synthesis
components SAM1 (At1g02500), ACS2 (At1g01480) and ACO1
(At2g19590), the b-galactosidases BGAL4 (At5g56870) and BGAL10
(At5g63810), and the cytosolic part (amino acids 1-79) of the
membrane-located potassium channel TPK1 (At5g55630). To this
end, all vectors were linearized at the LIC sites by PmeI digestion and
purified from contaminating stuffer fragment, followed by T4 DNA
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16 nt overhangs within the LCA or LCB sites (Fig. 4). All PCR-
amplified target open reading frames (see above) with LCA and LCB
complementary extensions at both ends (59 and 39) were treated with
T4 DNA polymerase in the presence of dTTP. For each target gene
two PCR products were generated using three primers in total: one
forward primer containing the LCA extension and the gene-specific
sequence, and two reverse primers containing the LCB extension and
the gene-specific sequence with or without a stop codon, respectively.
T4 DNA polymerase-treated PCR products with stop codon were
used for LIC into LC1 vectors encoding for N-terminal marker
proteins; PCR products without stop codon were used for LIC into
LC2 vectors encoding for C-terminal marker proteins (Fig. 4). The
complementary overhangs of the vectors and PCR products allowed
highly efficient and directed LIC, independent of the size of the target
open reading frames tested in this work. Cloning efficiency was
proven to be 100% by plasmid isolation and restriction analysis as
well as sequencing of all LIC-generated constructs after transforming
into competent cells. Features of all LIC-IFP vectors (ten in total) and
expression plasmids (54 in total) are summarized in Table 1.
Protein expression in vitro and in vivo using
LIC-IFP-compatible vectors: general aspects
Protein synthesis capability was investigated after LIC of target
open reading frames into the newly generated LIC-compatible
vectors using a commercial in vitro transcription/translation kit
(‘RTS 100 E. coli HY Kit’, derived from E. coli extracts) and several
in vivo systems including various E. coli strains [BL21 (DE3) pLysS,
BL21 (DE3) CodonPlus-RIL, Rosetta (DE3) pRARE, and BL21
Star (DE3) pRARE], K. lactis (GG799), P. pastoris (X33) and L.
tarentolae (P10); for details see Material and Methods.
Expression of fusion proteins in vitro or in vivo was analysed by
infrared scanning of the IFP moiety and/or by immunological
detection of the 6xHis-tag. In case of in vitro transcription/
translation, aliquots of crude protein extracts were transferred to
microtiter plates for infrared excitation (Fig. 5). In the case of in
vivo protein expression, intact cells were transferred to the
microtiter plates and analysed by infrared imaging (Fig. 5). As
reported before for protein production in Leishmania [21] this
allows pre-selection of well expressing cell lines at an early stage of
the expression pipeline. As infrared imaging of microtiter plates
does not allow distinguishing between full-length and truncated
IFP-containing proteins we additionally separated crude protein
extracts obtained by in vitro expression as well as pellet and
supernatant fractions of disrupted and ultracentrifuged in vivo
samples by SDS-PAGE; after gel electrophoresis the IFP moiety of
IFP fusion proteins was detected by in-gel infrared imaging
(estimated detection limit ,100 ng/lane; data not shown), and the
6xHis-tag was detected by western blot. We analyzed insoluble
pellet (protein precipitates, inclusion bodies) and soluble protein of
Figure 3. Nucleotide sequences of integrated oligonucleotide fragments. Sequences of integrated oligonucleotide fragments with features
common to all LIC-LC1 and LIC-LC2 vectors are shown. Double-stranded oligonucleotides were integrated at the restriction enzyme recognition sites
indicated except for PmeI which is used to eliminate the 670-bp stuffer fragment prior to the LIC process. LIC-pPICZ-LC1/-LC2 vectors were generated
by inserting AclI/SalI-restricted double-stranded oligonucleotides into BstBI/SalI-digested expression vector (cutting with AclI and BstBI creates
compatible 59 overhangs), resulting in a change of the BstBI sequence (TTCGAA to TTCGTT). The asterisk on the forward strand indicates the position
of adenine (corresponding to thymine on the reverse strand) required for the generation of LIC 59 overhangs in the presence of T4 DNA polymerase
and dATP. The blue arrow indicates the TEV cleavage site suitable for the removal of the marker proteins IFP and 6xHis-tag.
doi:10.1371/journal.pone.0018900.g003
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expressed proteins in the different expression systems.
In vitro protein expression of IFP fusion proteins using
LIC-pIVEX-LC1/-LC2 vectors
Protein synthesis employing the newly generated LIC-pIVEX-
LC1/-LC2 in vitro expression vectors was investigated using five
different target proteins, i.e. ANAC042, ANAC059, SAM1, ACS2
and ACO1, fused in both orientations (N- and C-terminal) to the
marker proteins IFP and 6xHis-tag, resulting in a total of ten
fusion proteins. Six or eight of the ten IFP fusion proteins were
detected by in-gel imaging (Fig. 6, upper panel; 6xHis-IFP-TEV-
SAM1/-ACO1/-ANAC042/-ANAC059 and SAM1-/ACO1-
TEV-IFP-6xHis) or western blot (Fig. 6, lower panel; 6xHis-
IFP-TEV-SAM1/-ACO1/-ANAC042/-ANAC059 and SAM1-/
ACO1-/ANAC042-/ANAC059-TEV-IFP-6xHis) indicating that
in-gel detection in combination with immunological detection is a
powerful tool for the analysis of proteins fused to the marker
proteins used in this work. ACS2 was the only target protein that
was not expressed or could not be detected, independent of its
orientation relative to the fused marker proteins. Of note, infrared
imaging generated clearly detectable signals only in the presence of
IFP fusion proteins, with low or no background signal (Fig. 6). An
important observation was that in vitro protein synthesis was almost
completely blocked when biliverdin hydrochloride (dissolved in
dimethyl sulfoxide, DMSO) was present in the transcription/
translation mix. Therefore, for efficient protein expression and
development of infrared signal, biliverdin hydrochloride had to be
added after finishing in vitro protein synthesis.
Protein expression in E. coli using LIC-pDEST-LC1/-LC2
vectors
Protein synthesis capability of the E. coli LIC-pDEST-LC1/
-LC2 expression vectors was investigated using four different
E. coli expression strains and seven different target proteins, i.e.
ANAC042, ANAC059, SAM1, ACS2, ACO1, BGAL4 and
BGAL10. Except for SAM1, ACS2 and ACO1 all proteins were
fused in both orientations (N- and C-terminal) to the IFP- and
6xHis-tags, resulting in a total of eleven fusion proteins. Ten or
eleven of the IFP fusion proteins were detected by in-gel infrared
imaging (Fig. 7, upper panel) or immunologically (Fig. 7, lower
panel). BGAL4-TEV-IFP-6xHis was the only protein that could
not be detected by in-gel detection. As for in vitro expression (and
expression in other organisms, see below), clear infrared signal was
only detected in the presence of IFP fusion proteins. BGAL4 and
BGAL10 exclusively accumulated in the insoluble fraction. Most
other fusion proteins (ANAC042, ANAC059, SAM1, ACS2 and
ACO1) had greater proportions of insoluble protein but were also
present as soluble proteins detectable by in-gel infrared imaging
and western blot analysis. Although it is known that expression at
lower temperatures may increase the proportion of soluble protein
[12] an optimization of the expression parameters was not
attempted in this study as this greatly depends on the expressed
protein. Furthermore, the solubility of proteins expressed in E. coli
may be increased by selecting expression strains with different
characteristics, e.g. those supporting the formation of disulfide
bonds in their cytoplasm (Rosetta gami 2 (DE3) pLacI; Merck) or
by using an improved BL21 host strain for soluble protein
expression (SoluBL21; AMS Biotechnology, Abingdon, UK) [32].
Whilst in vitro expression of IFP or IFP fusion proteins has to be
carried out in the absence of biliverdin hydrochloride, protein
expression in E. coli is seemingly not affected by its presence.
Instead of biliverdin hydrochloride, also hemin can be fed, which
upon co-expression of a cyanobacterial heme oxygenase (HO-1) is
converted to biliverdin in E. coli (data not shown, and [20]). Using
hemin instead of biliverdin hydrochloride may reduce costs,
however, for co-expression using two expression vectors a third
antibiotic selection marker (for maintenance of the HO-1
expression vector) is then required. Thus, for both, IFP fusion
protein screening in E. coli in small expression volumes and up-
scaling of protein expression in larger volumes we recommend to
Figure 4. Ligation-independent cloning using LIC-IFP-compatible expression vectors. LIC vectors (LIC-LC1 and LIC-LC2) are cleaved with
PmeI restriction enzyme and the released stuffer fragment (670 bp) is removed. The cleaved vector is treated with T4 DNA polymerase in the
presence of dATP, whereas the PCR product (amplified open reading frame) is treated in the presence of dTTP. The asterisks indicate the position of
adenine (vector) or thymine (PCR product) required for the generation of LIC-complementary 59 overhangs. After successful annealing and
transformation into E. coli, host-internal ligases and DNA polymerases close the vector and fill in the gaps, caused by the two additional nucleotides
(CC, coloured in blue) upstream of the start codon (ATG), which are required to retain the reading frame. For LIC with LC1 vectors, PCR-amplified
open reading frames contain a double stop codon (TAATAG); for LIC with LC2 vectors, open reading frames must not contain a stop codon to allow
expression of ProteinX-TEV-IFP-6xHis fusion proteins. To provide the thymine moiety on the forward strand for dTTP/T4 DNA polymerase treatment,
additional three nucleotides (GGT) are added directly at the 39-end of the PCR-amplified open reading frame.
doi:10.1371/journal.pone.0018900.g004
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Host Parental LIC-IFP vector Expression vectors/MW
vector (leader sequence)

























K. lactis pKLAC1 LIC-pKLAC-LC1 LIC-pKLAC-LC1-SAM1/81.7 kDa
(6xHis-IFP-TEV-LIC) LIC-pKLAC-LC1-ACO1/73.8 kDa
LIC-pKLAC-LC1-ANAC059/74.4 kDa
K. lactis pKLAC1 LIC-pKLAC-LC2 LIC-pKLAC-LC2-SAM1/81.7 kDa
(LIC-TEV-IFP-6xHis) LIC-pKLAC-LC2-ACO1/73.7 kDa
LIC-pKLAC-LC2-ANAC059/74.3 kDa
















L. tarentolae pLEXSY-sat2 LIC-pLEXSY-LC2 LIC-pLEXSY-LC2-TPK1(1-79)/47.6 kDa
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hydrochloride, followed by disruption of harvested cells in lysis
buffer that contains biliverdin hydrochloride.
Protein expression in K. lactis, P. pastoris and L. tarentolae
using LIC-pKLAC-LC1/-LC2, LIC-pPICZ-LC1/-LC2 and
LIC-pLEXSY-LC1/-LC2 vectors
Protein synthesis capability of the newly generated expression
vectors LIC-pKLAC-LC1/-LC2 (K. lactis), LIC-pPICZ-LC1/-
LC2 (P. pastoris) and LIC-pLEXSY-LC1/-LC2 (L. tarentolae) was
investigated by expressing various numbers of proteins from the
following collection: ACO1, ACS2, ANAC042, ANAC059,
BGAL4, BGAL10, TPK1(1-79), and SAM1. Two proteins
(BGAL4 and BGAL10) contained C-terminal fusions to IFP and
the 6xHis-tag, and the remaining six proteins harboured fusions to
both tags at their N- or C-terminus. Figure 8 shows the results
obtained by in-gel imaging (upper panels in A to C) and western
blot analysis (lower panels). In the case of K. lactis most proteins
were detected by in-gel imaging and immunologically (Fig. 8A).
Whilst 6xHis-IFP-TEV-SAM1 accumulated exclusively in the
soluble fraction and ANAC059-TEV-IFP-6xHis in the insoluble
fraction, the remaining proteins (6xHis-IFP-TEV-ACO1 and
SAM1-/ACO1-TEV-IFP-6xHis) were present in the soluble and
insoluble fractions. Several proteins were also successfully
expressed in P. pastoris (Fig. 8B). However, 6xHis-IFP-TEV-
ACS2/-ACO1 proteins (Fig. 8B) and the four b-galactosidase
fusions (6xHis-IFP-TEV-BGAL4/-BGAL10 and BGAL4-/










Figure 5. Infrared analysis of in vitro and in vivo expressed IFP fusion proteins. Infrared scanning of all samples was performed in microtiter
plates using the Odyssey Infrared Imaging System from LI-COR Biosciences. (A) In vitro transcription/translation products were analysed by infrared
scanning using the whole reaction mixtures. 6xHis-GFP and IFP-6xHis fusion protein-expressing samples were used as negative (-) and positive (+)
controls, respectively. (B) In-cell detection of IFP fusion protein (6xHis-IFP-TEV-ANAC042 shown as an example) in two randomly selected clones each
from the E. coli strains (BL21 (DE3) pLysS (‘pLysS’), BL21 Star (DE3) pRARE (‘Star’), BL21 (DE3) CodonPlus-RIL (‘Codon’), and Rosetta (DE3) pRARE
(‘Rosetta’). 6xHis-GFP and IFP-6xHis fusion protein-expressing cells were used as negative (-) and positive (+) controls, respectively. (C), (D) and (E) In-
cell detection of IFP fusion protein (SAM1-TEV-IFP-6xHis shown as an example) in randomly selected K. lactis, P. pastoris and L. tarentolae clones. Cell
lines not expressing IPF or expressing IFP-6xHis fusion protein were used as negative (-) and positive (+) controls, respectively. No positive control was
available for expression in K. lactis. Note that strong infrared signal appears white in the digital images.
doi:10.1371/journal.pone.0018900.g005
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produced by this organism. In L. tarentolae, seven IFP fusion
proteins were expressed, i.e. 6xHis-IFP-TEV-TPK1(1-79) and
TPK1(1-79)-/SAM1-/ACS2-/ACO1-/BGAL4-/BGAL10-TEV-
IFP-6xHis, and detected by in-gel imaging (Fig. 8C, upper panel)
and western blot (Fig. 8C, lower panel). ANAC042 fused to the
marker proteins in both orientations as well as 6xHis-IFP-TEV-
BGAL4- and -BGAL10 proteins were not visibly expressed in
Leishmania (not shown).
Taken together, in-gel detection resulted in clearly visible
infrared signals in all expression systems in the presence of IFP or
IFP fusion proteins with biliverdin hydrochloride or hemin as co-
factor. Truncated IFP fusion proteins were occasionally observed
(e.g. Fig. 6, IFP-SAM1 or IFP-ACO1) and were likely due to
protein instability, premature termination of protein synthesis or
translation initiation at internal ribosome binding sites. However,
if wanted, this can be optimized by e.g. the addition of protein
stabilizing components (e.g. glycerin) or changing expression
parameters (expression time and temperature, concentration of
inducers, changing expression strains), using additional protease
inhibitors, or optimizing protein-coding sequences by gene
synthesis to adapt codon usage, modify secondary RNA structures
and avoid internal ribosome binding sites. For protein expression
in Leishmania we used media containing hemin. However, in K.
lactis and P. pastoris, the continous presence of hemin had a
negative effect on protein formation and/or the intensity of the
IFP signal. In these cases we therefore added hemin only two
hours before cell culture and protein expression was stopped. The
eukaryotic expression systems used in this report are able to
express functional IFP or IFP fusion proteins with hemin as co-
factor, indicating that hemin can be catabolized by Leishmania (as
previously shown) [21], K. lactis and P. pastoris.
Purification of IFP fusion proteins with TEV-accessible
cleavage sites
We next tested the functionality of the 6xHis and TEV leader
sequences fused in both orientations (N- and C-terminal) to
various IFP fusion proteins, i.e. 6xHis-IFP-TEV-SAM1/-ACO1
and ANAC042-/ANAC059-TEV-IFP-6xHis, expressed in E. coli.
Functionality of the 6xHis tag was analysed by affinity purification
of all proteins under non-denaturing conditions, using Protino NI-
IDA 150 columns. Purification was accompanied by infrared
analysis of 50-mL aliquots of each fraction in microtiter plates
(Fig. 9A), followed by in-gel detection of IFP fusion proteins after
SDS-PAGE (Fig. 9B, upper panel) or Coomassie staining of
protein bands (Fig. 9B, lower panel). Figure 9 clearly
demonstrates that IFP fusion proteins can be easily purified by
virtue of their 6xHis tag, irrespective of whether IFP is fused to
target proteins via their N- or C-terminus. Importantly, purifica-
tion of IFP fusion proteins can be easily monitored either during or
at the end of the purification process by infrared analysis in
microtiter plates or by in-gel detection after SDS-PAGE
separation. However, only in-gel imaging or western blot analysis
can reveal whether the infrared signal detected in microtiter plates
is derived from full-length IFP fusion proteins or truncated IFP
molecules.
We also tested the functionality of the TEV cleavage site. To
this end, cells were disrupted and IFP fusion proteins were treated
with TEV protease. Time-dependent changes of infrared signal
intensity were monitored by in-gel detection after SDS-PAGE of
TEV-treated proteins. Whilst infrared signal intensities of full-
length IFP fusion proteins decreased over time, a clear increase of
infrared signal intensity was observed for the released IFP moiety
within 4h for all proteins analyzed (Fig. 9C), clearly demonstrat-
ing the functionality of the TEV cleavage site in IFP fusion
proteins.
Monitoring protein-protein interactions based on IFP
fusions
We reasoned that IFP might not only be useful as an easy-to-
handle reporter for protein expression in vitro and in vivo but may
also be beneficial in other experiments where proteins need to be
monitored. We therefore first tested whether IFP can be used as a
reporter in protein-protein interaction studies and then analyzed
whether it could also be employed to monitor protein-DNA
interactions (see below).
To investigate the potential value of IFP as a reporter for
protein-protein interactions, we expressed GRF1 - GRF6 proteins
from Arabidopsis thaliana as GST fusions and tested whether they
interact with the potassium channel TPK1 in pull-down assays.
We have previously shown by yeast two-hybrid analysis that the
amino-terminal segment of TPK1 (encompassing amino acids 1-
79) interacts with GRF1 - GRF6 [33]. Except for two interactions
(TPK1 with GRF2 and GRF4), all other interactions were verified
by either pull-down analysis based on GST fusions (interaction of
TPK1(1-79) with GRF1 and GRF6) [29] or Bimolecular
Fluorescence Complementation (BiFC) experiments (interaction
of TPK1(1-79) with GRF3, 5 and 6) [33]. Here, we demonstrate
physical interactions of TPK1(1-79) expressed as TPK1(1-79)-
TEV-IFP-6xHis fusion protein with all GRFs tested (GRF1 –
GRF6).
GST-GRF fusion proteins were expressed in E. coli and affinity-
purified by A ¨kta-FPLC using a 1-mL GSTrap column. Ten mLo f
the elution steps (1-mL fractions) were separated by SDS-PAGE
and protein bands were visualized by Coomassie staining
(Fig. 10A). Full-length GST-GRF fusion proteins in the range
of 1–10 mg per mL of E. coli expression culture were obtained.
Infrared-functional TPK1(1-79)-TEV-IFP-6xHis fusion protein
was purified from L. tarentolae by A ¨kta-FPLC using a 1-mL
HisTrap HP column. Ten mL of the collected unbound flow-
through, as well as flow-through of wash and elution steps (1-mL
fractions) were separated by SDS-PAGE and analyzed by in-gel
detection for infrared fluorescence directly in the cast protein gel
(Fig. 10B, upper panel) followed by Coomassie staining for
Figure 6. LIC cloning and expression of IFP fusion proteins in
vitro. In vitro expressed IFP fusion proteins were separated by SDS-
PAGE and analysed by in-gel detection directly in the cast gel at 700 nm
(upper panel) followed by western transfer and immunological
detection at 800 nm (lower panel). Plasmid-free translation extract (-),
as well as samples expressing 6xHis-GFP fusion protein (-/+) or IFP-6xHis
fusion protein (+) were used as controls. Detected or expected protein
bands are labelled by dashed frames or asterisks, respectively. M,
molecular mass marker (kDa).
doi:10.1371/journal.pone.0018900.g006
LIC-IFP Based Protein Expression Platform
PLoS ONE | www.plosone.org 12 April 2011 | Volume 6 | Issue 4 | e18900Figure 7. Expression of IFP fusion proteins in E. coli. Protein extracts obtained from IFP fusion protein-expressing E. coli strains BL21 (DE3)
pLysS (‘pLysS’), BL21 Star (DE3) pRARE (‘Star’), BL21 (DE3) CodonPlus-RIL (‘Codon’), and Rosetta (DE3) pRARE (‘Rosetta’) were separated by SDS-PAGE
and analysed by in-gel infrared imaging at 700 nm to detect IFP moieties (upper panel), followed by western transfer and immunological detection at
800 nm (using monoclonal mouse antibody directed against the 6xHis epitope; lower panel). IFP-6xHis fusion protein-expressing cells were used as
positive control. Supernatant (S) and pellet (P) fractions of disrupted cells were analyzed after ultracentrifugation. M, molecular mass marker (kDa).
Arrows indicate expected proteins.
doi:10.1371/journal.pone.0018900.g007
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images (Fig. 10B and C) demonstrate that both fusion proteins,
TPK1(1-79)-TEV-IFP-6xHis and IFP-6xHis, are expressed and
detected as full-length proteins in the gel when excited at 700 nm.
Concentrations of the purified proteins (GST, GST-GRFs,
TPK1(1-79)-TEV-IFP-6xHis and IFP-6xHis) were determined by
SDS-PAGE separation and Coomassie staining in the presence of
BSA standard (data not shown) before interaction analysis was
started. Subsequently, for the co-affinity purification experiments
equal amounts of GST and GST-GRFs were immobilized to
glutathione agarose beads and incubated with equal amounts of
purified TPK1(1-79)-TEV-IFP-6xHis or IFP-6xHis in different
combinations: (i) GST immobilized to the beads and incubated
with TPK1(1-79)-TEV-IFP-6xHis fusion protein was used as
negative control in order to eliminate unspecific interactions of the
TPK1(1-79)-IFP-6xHis fusion protein with the beads or with the
GST part of the GST-GRF fusion proteins. (ii) As a second
negative control, to avoid unspecific binding of IFP-6xHis protein
to the beads or to the GST part of GST-GRF fusion proteins, we
incubated bead-immobilized GST with IFP-6xHis protein. Co-
affinity purifications were done in the presence of BSA as
competing protein, and under stringent conditions in the presence
of the detergent Nonidet-P40. Co-purified proteins were specifi-
cally eluted from the beads using reduced glutathione and
analyzed in microtiter plates followed by in-gel detection
(Fig. 10D and E). Figure 10D (wells A3 to A9) clearly
demonstrates that there is neither (or only weak) unspecific
binding of TPK1(1-79)-TEV-IFP-6xHis to immobilized GST nor
of IFP-6xHis to immobilized GST-GRFs. In contrast strong
infrared signals can be seen in wells B4 to B9 indicating physical
interactions between GRF proteins with the TPK1(1-79) moiety of
the TPK1(1-79)-TEV-IFP-6xHis fusion protein. This result was
verified by in-gel detection (Fig. 10E) where full-length TPK1(1-
79)-TEV-IFP-6xHis fusion protein can only be seen in lanes where
interacting proteins were specifically eluted from the beads.
Monitoring of protein-DNA interactions based on IFP
fusions
Protein-DNA interactions play an important role in many
biological processes, e.g. DNA packaging, transcriptional regula-
tion and DNA replication, besides others. Transcription factors
(TFs) are proteins that interact in a sequence-specific manner with
cis-elements in promoters of target genes. Discovering binding sites
for TFs and the promoters to which they bind is of prime
importance for the understanding of gene regulatory networks
they control. Here we intended to test whether TF-IFP fusion
proteins can be used to demonstrate binding of TFs to cis-elements
in vitro, using the Arabidopsis thaliana NAC TF ANAC042 as a test
Figure 8. Expression of IFP fusion proteins in eukaryotic cells. Proteins extracted from (A) Kluyveromyces lactis,( B) Pichia pastoris and (C)
Leishmania tarentolae were separated by SDS-PAGE and analysed by in-gel infrared imaging at 700 nm to detect IFP moieties (upper panels),
followed by western transfer and immunological detection at 800 nm (using monoclonal mouse antibody directed against the 6xHis epitope; lower
panels). Supernatant (S) and pellet (P) fractions of disrupted cells were used for analysis after ultracentrifugation. Detected or expected protein bands
are labelled by dashed frames or asterisks, respectively. IFP fusion proteins present in pellet fractions from P. pastoris did not separate as distinct
bands. M, molecular mass marker (kDa).
doi:10.1371/journal.pone.0018900.g008
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of longevity in Arabidopsis. ANAC042 binds to a bipartite cis-
regulatory element, as shown by in vitro binding site selection assay
(Wu et al., manuscript in preparation). Through mutational
analysis we identified nucleotide positions within the ANAC042
binding sites important for binding of the TF. Here, to establish an
IFP-based DNA-protein interaction assay, we chose both, the
wild-type cis-element and a mutant version of it that in previous in
vitro experiments (using CELD-based binding-site selection assay)
[34] displayed only 7% binding affinity (B-7%-DNA) compared to
the wild-type sequence (B-100%-DNA).
We expressed ANAC042-TEV-IFP-6xHis and IFP-6xHis fusion
proteins in E. coli. After purification using Protino NI-IDA 150
columns (Macherey & Nagel) infrared-functional proteins were
detected by infrared imaging after SDS-PAGE (Fig. 11A, upper
panel). BSA standard used for quantification was only visible after
Coomassie staining; calibration revealed purified proteins to be in
the range of 1-10 mg per mL of E. coli culture (Fig. 11A, lower
panel). For protein-DNA interaction experiments equal amounts
(,5 mg) of ANAC042-TEV-IFP-6xHis and IFP-6xHis fusion
proteins were incubated with biotinylated DNA molecules (B-
100%-DNA or B-7%-DNA) immobilized on streptavidin mutein
particles. Control and experimental settings were as follows: (i)
Beads with immobilized B-100%-DNA or B-7%-DNA were
incubated with IFP-6xHis protein and used as negative controls;
this treatment was expected to minimize unspecific interaction of
the ANAC042-TEV-IFP-6xHis fusion protein with the beads or
the immobilized DNA molecules. ii) Beads with immobilized B-
100%-DNA or B-7%-DNA were incubated with ANAC042-TEV-
IFP-6His fusion protein and used as experiments. All protein-DNA
interactions were carried out in the presence of competing DNA:
particles with immobilized B-100%-DNA or B-7%-DNA were
incubated with non-biotinylated 7%-DNA or 100%-DNA,
respectively, for incubation with IFP-6xHis (negative control)
and ANAC042-TEV-IFP-6xHis (experiment) proteins. Interacting
DNA protein complexes were specifically eluted from the beads
and analyzed in microtiter plates followed by in-gel detection and
western blot analysis (Fig. 11B and C, upper and lower panel).
Figure 11B (positions A3 and A4 of a microtiter plate) clearly
demonstrates the absence of unspecific binding of IFP-6xHis
fusion protein to immobilized B-100%-DNA or B-7%-DNA. In
contrast, strong binding to B-100%-DNA was observed for
ANAC042-TEV-IFP-6xHis protein (position B3), whereas binding
of the IFP-labeled transcription factor to B-7%-DNA was weak
(position B4). Quantitative analysis using the in silico labeling and
quantification tool of the Odyssey Infrared Imaging System (LI-
COR) revealed integrated signal intensities of 319 and 50,
respectively, when ANAC042-TEV-IFP-6xHis fusion protein
Figure 9. Purification of IFP fusion proteins with accessible TEV cleavage sites. Fusion proteins, i.e. 6xHis-IFP-TEV-SAM1/-ACO1 (LC1-SAM1,
82 kDa and LC1-ACO1, 74 kDa) and ANAC042-/ANAC059-TEV-IFP-6xHis (LC2-ANAC042, 70 kDa and LC2-ANAC059, 74 kDa) expressed in E. coli were
either used for affinity purification with Protino NI-IDA 150 columns after ultracentrifugation (A, B)o r( C) TEV cleavage experiments directly in crude
extracts. (A, B) Input (row and lane ‘I’) and 50-mL aliquots of the fractions ‘unbound’ (row and lane ‘U’), ‘wash’ (row and lane ‘W’) and ‘elution’ (rows
and lanes ‘E1’ to ‘E5’) were analyzed by infrared imaging in (A) microtiter plates (control corresponds to E. coli cells expressing GST alone; note that
strong infrared signal appears white in the digital image) or by in-gel detection and Coomassie staining (B, upper and lower panel) after SDS-PAGE
separation. (C) Aliquots of untreated (lane ‘-’) or 1 h, 2 h and 4 h TEV protease-treated crude extracts (lanes ‘1 h’, ‘2 h’ and ‘4 h’) were analysed by in-
gel detection after SDS-PAGE separation. Dashed lines indicate the time-dependent decrease (red dashed boxes) or increase (green dashed boxes) of
full-length IFP fusion proteins or released IFP moieties, respectively. M, molecular mass marker (kDa).
doi:10.1371/journal.pone.0018900.g009
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(Fig. 11B). This result is therefore close to the data obtained
independently with the CELD-based binding site selection assay
(Wu et al., manuscript in preparation). The B-100%-DNA and B-
7%-DNA differ by only two base-pairs (along a stretch of 18 base-
pairs in total). According to the results obtained before and
observed in this report (presented as integrated signal intensities in
Figure 11B) a change from GT (in B-100%-DNA) to AA (in B-
7%-DNA) strongly reduces interaction with the ANAC042
transcription factor. Thus, results obtained with the IFP-based
DNA pull-down assay favorably compare with protein-DNA
interaction data obtained using independent experimental setups.
Enzymatic activity assays using IFP fusion proteins
Two lignocellulolytic enzymes, endo-b-1,4-glucanase and endo-
b-1,4-xylanase derived from the fungus Emericella nidulans, were
Figure 10. Protein-protein interaction analysis based on GST-pull down, using IFP reporter. (A) Fusion proteins GST-GRF1 (58 kDa), -
GRF2 (57 kDa), -GRF3 (56 kDa), -GRF4 (58 kDa), -GRF5 (58 kDa) and -GRF6 (56 kDa) were expressed in E. coli, affinity-purified and analysed (1-mL
fractions) by SDS-PAGE and Coomassie staining. (B) TPK1(1-79)-TEV-IFP-6xHis fusion protein (48 kDa) expressed in L. tarentolae and purified by affinity
chromatography. One-mL fractions ‘unbound’ (lane 1), ‘washed’ (lanes 2 and 3) and ‘elution’ (lanes 4-7) were separated by SDS-PAGE and infrared-
scanned (upper panel) followed by Coomassie staining (lower panel). (C) Signal intensities of purified fusion proteins IFP-6xHis (lane 1: 3 mL; lane 2:
5 mL) and TPK1(1-79)-TEV-IFP-6xHis (lane 3: 3 mL; lane 4: 5 mL; lane 5: 10 mL), isolated from L. tarentolae, were analysed by infrared-scanning after SDS-
PAGE (upper panel), followed by western blot analysis (lower panel). (D) GST-fusion proteins immobilized on glutathione agarose beads and
incubated with purified TPK1(1-79)-TEV-IFP-6xHis fusion protein. After elution, fractions were scanned at 700 nm (microtiter plate). A1: IFP-6xHis
input. A2: TPK1(1-79)-TEV-IFP-6xHis input. A3: negative control with GST immobilized on glutathione agarose beads + TPK1(1-79)-TEV-IFP-6xHis. A4/5/
6/7/8/9: negative controls with GST-GRF1/2/3/4/5/6 immobilized on glutathione agarose beads + IFP-6xHis. B1/2/3: empty wells. B4/5/6/7/8/9: GST-
GRF1/2/3/4/5/6 immobilized on glutathione agarose beads + TPK1(1-79)-TEV-IFP-6xHis. White representation in the digital image indicates strong
infrared signal. (E) After infrared-scanning in microtiter plates (see D) samples were separated by SDS-PAGE and scanned at 700 nm. Lane ‘M’,
molecular mass marker (in kDa) supplemented with IFP-6xHis protein (red square). This protein was omitted from the marker in the last lane. Lane 1:
TPK1(1-79)-TEV-IFP-6xHis (red square) input. Lane 2: negative control with GST immobilized on glutathione agarose beads + TPK1(1-79)-TEV-IFP-6xHis.
Lanes 3/5/7/9/11/13: additional negative controls with GST-GRF1/2/3/4/5/6 immobilized on glutathione agarose beads + IFP-6xHis. Lanes 4/6/8/10/
12/14: experiments with GST-GRF1/2/3/4/5/6 immobilized on glutathione agarose beads + TPK1(1-79)-TEV-IFP-6xHis.
doi:10.1371/journal.pone.0018900.g010
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were shown before to be active on carboxymethylcellulose (CMC)
or xylan substrate after expression in Pichia pastoris as Myc-6xHis-
tag fusion proteins [30]. To our knowledge both proteins were not
expressed in E. coli before. Here we cloned the open reading
frames of the two enzymes, via LIC, into the E. coli expression
vectors LIC-pDEST-LC1 and -LC2. Resulting expression vectors
encoding for a total of four IFP fusion proteins were transformed
into different E. coli expression strains and investigated on CMC or
xylan agar plates for enzymatic activity after Congo Red staining
(Fig. 12). IFP-6xHis fusion protein-expressing E. coli strains were
used as negative controls and Pichia pastoris strains expressing and
secreting active endo-b-1,4-glucanase-myc-6xHis and endo-b-1,4-
xylanase-myc-6xHis fusion proteins [30] were used as positive
controls. On CMC agar plates (Fig. 12, left panel) characteristic
clear zones were observed when endo-b-1,4-glucanase was
expressed as endo-b-1,4-glucanase-TEV-IFP-6xHis fusion protein
in all E. coli strains tested here (however, no glucanase activity was
detected when the enzyme was fused to 6xHis-IFP-TEV at its N-
terminus). On xylan-containing agar plates (Fig. 12, right panel)
characteristic dark halos were observed when endo-b-1,4-xylanase
was expressed in the different E. coli strains as fusions to IFP and
6xHis. Thus, it can be concluded that at least for the two enzymes
tested here, fusions to IFP did not largely impair their enzymatic
activity.
Discussion
Efficient methods for the cloning, expression and functional
analysis of proteins are highly wanted in functional genomics
research. Here we established a LIC-IFP-based protein expression
platform that combines various beneficial characteristics: very high
(generally 100%) cloning efficiency due to a slightly modified LIC
procedure (including a stuffer fragment between two LIC sites in
the target vectors); multi-parallel, oriented insertion of LIC-
enabled PCR fragments (obtained by only two separate PCR
reactions) into different vectors for expression in prokaryotic and
eukaryotic hosts and in vitro; simple detection of expressed proteins
in intact cells by infrared imaging; facile infrared visualization of
expressed proteins in crude protein extracts after denaturing SDS-
PAGE directly in the cast gels. IFP not only serves as an
exceptional marker for protein expression in vivo and in vitro, its
excellent reporter properties may also trigger the development of
new molecular and biochemical detection methods such as those
reported here for the analysis of protein-protein and protein-DNA
interactions.
In their original paper Shu et al. [20] reported successful
expression of IFP in E. coli, human embryonic kidney cells
(HEK293A), and mice. We recently demonstrated that IFP also
functions as an excellent reporter for protein expression in the
protozoan Leishmania tarentolae [21]. Here we show that IFP has
similar beneficial properties in two further eukaryotic hosts, i.e. the
yeasts Kluyveromyces lactis and Pichia pastoris. Although we have not
Figure 11. Protein-DNA interaction analysis based on IFP
fusions. (A) Fusion proteins ANAC042-TEV-IFP-6xHis (70 kDa) and
IFP-6xHis (36 kDa) affinity-purified from E. coli. Two elution fractions
(26250 mL) containing the purified proteins were pooled and analysed
after SDS-PAGE by in-gel detection (top) and Coomassie staining
(bottom) (lanes 10–13: ANAC042-TEV-IFP-6xHis, 5, 10, 15, and 20 mL;
lanes 6 - 9: IFP-6xHis, 2, 5, 8 and 10 mL). BSA served as standard to
estimate protein amounts (lanes 1–5: 100/250/500/750/1000 ng). Equal
amounts of both proteins (,5 mg) were used for protein-DNA
interaction analysis. M, molecular mass marker (kDa). (B) Biotinylated
dsDNA was immobilized on streptavidin mutein particles and incubated
with ANAC042-TEV-IFP-6xHis protein. After elution, fractions were
scanned at 700 nm in the wells of a microtiter plate (strong infrared
signal appears white in the digital image). A1: IFP-6xHis input. A2:
ANAC042-TEV-IFP-6xHis input. A3: negative control; B-100%-DNA
immobilized on streptavidin mutein particles + IFP-6xHis in the
presence of non-biotinylated 7%-DNA. A4: negative control; B-7%-
DNA immobilized on streptavidin mutein particles + IFP-6xHis, in the
presence of non-biotinylated 100%-DNA. B1/2: empty wells. B3/4:
experiments with B-100%-DNA and B-7%-DNA immobilized on
streptavidin mutein beads + ANAC042-TEV-IFP-6xHis incubated in the
presence of non-biotinylated 7%- and 100%-DNA, respectively. Areas of
the infrared signals were marked (white circles) and integrated signal
intensities were calculated (B3=319, and B4=50). (C) After infrared-
scanning in microtiter plates (see B) samples were separated by SDS-
PAGE and scanned at 700 nm (top) followed by western blot analysis
(bottom). Lane 1: IFP-6xHis input (white square). Lane 2: ANAC042-TEV-
IFP-6xHis input (white square). Lane 3: negative control with B-100%-
DNA immobilized on streptavidin mutein particles + IFP-6xHis, in the
presence of non-biotinylated 7%-DNA. Lane 4: experiment with B-
100%-DNA immobilized on streptavidin mutein particles + ANAC042-
TEV-IFP-6xHis, in the presence of non-biotinylated 7%-DNA. Lane 5:
negative control with B-7%-DNA immobilized on streptavidin mutein
particles + IFP-6xHis, in the presence of non-biotinylated 100%-DNA.
Lane 6: experiment with B-7%-DNA immobilized on streptavidin mutein
particles + ANAC042-TEV-IFP-6xHis, in the presence of non-biotinylated
100%-DNA.
doi:10.1371/journal.pone.0018900.g011
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perform as a novel reporter in other microbial systems as well.
Furthermore, as shown in this report, functional IFP can be easily
and rapidly reconstituted after in vitro transcription/translation.
Using the LIC-compatible vectors provided here, also untagged
proteins can be produced. To this end, open reading frames are
amplified with a reverse primer that includes a stop codon before
cloning into LC2 vectors. Additionally, although not tested, the
LIC-pIVEX-LC1/-LC2 vectors designed for in vitro expression in
E. coli-derived transcription/translation extract may be modified to
function in other T7-based in vitro expression systems, e.g. rabbit
reticulocytes or wheat germ lysates. The LIC-IFP cloning and
expression setup can also easily be extended to other vectors for
expression in alternative hosts. In principal, LIC-IFP vectors could
also be designed for protein expression in plants; however, plant
cells often accumulate secondary metabolites and chlorophyll that
intensely fluoresce when illuminated with infrared light used for
IFP detection (not shown). Finally, the LIC-IFP vectors may be
modified to include other cloning features, such as those realized
in e.g. Golden Gate shuffling [6] or In-Fusion assembly (Clontech).
A further important result of our studies is that IFP classifies as
an easy-to-handle reporter not only for the detection of protein
expression in cells, but also for the visualisation of protein-protein
and protein-DNA interactions in vitro. Protein-protein and protein-
DNA interactions are key mechanisms for numerous biological
functions in living cells and a suite of techniques has therefore been
developed in the last decade to support the analysis of such
interactions, including the yeast two- and one-hybrid systems,
bimolecular fluorescence complementation, co-immunoprecipita-
tion, DNA electrophoretic mobility shift assays, or pull-down
assays, besides others. Here, we modified existing protein-protein
and protein-DNA pull-down assays that traditionally detect
interactions between bio-molecules by autoradiography using
radioactively (
35S-methionine) labeled proteins or by western blot
using antibodies directed against the protein under analysis or an
attached epitope tag. In our approach we appended IFP to
proteins of interest and visualized their interactions with other
proteins or DNA by infrared imaging in either cast protein gels
(after SDS-PAGE) or in microtiter plates. Of note, with our IFP-
based DNA-protein interaction assay we were able to demonstrate
differential binding affinity to wild-type and mutated DNA cis-
elements which closely matched our previous observations. We
thus conclude that our novel protocol represents a simple and
straightforward alternative for the confirmation of protein-protein
and protein-DNA interactions that have e.g. been observed before
in a yeast one-hybrid or CELD assay. Finally, using two cell wall-
degrading enzymes as model proteins we demonstrated that our
vector set allows rapid expression of IFP fusion proteins that retain
catalytic activity.
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Figure 12. Enzymatic activity assays using glucanase- and xylanase-IFP fusion proteins expressed in E. coli. LIC-pDEST-LC1-/LC2 vectors
encoding 6xHis-IFP-TEV-endo-b-1,4-glucanase/-xylanase and endo-b-1,4-glucanase-/xylanase-TEV-IFP-6xHis fusion proteins were transformed into the
E. coli strains BL21 (DE3) pLysS (‘pLysS’), BL21 Star (DE3) pRARE (‘Star’), BL21 (DE3) CodonPlus-RIL (‘Codon’) and Rosetta (DE3) pRARE (‘Rosetta’).
Enzymatic activity was tested by Congo Red staining and destaining with 1 M NaCl on carboxymethylcellulose- (left panel) or xylan- (right panel)
containing agar plates after transferring 2 mL of the respective expression strains and over-night incubation at 37uC. Glucanase activity leads to the
formation of a white halo around the colonies, whereas xylanase activity leads to the formation of a black halo [31]. E. coli cells expressing IFP-6xHis
fusion protein were used as negative control, and cell-free supernatant of Pichia pastoris expression cultures containing secreted endo-b-1,4-
glucanase-myc-6xHis or endo-b-1,4-xylanase-myc-6xHis fusion proteins were used as positive controls (P).
doi:10.1371/journal.pone.0018900.g012
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